Skyrizi (risankizumab)

pCPA File Number: 22367
Negotiation Status:
Concluded with an LOI
Indication(s):
Moderately to severely active Crohn's disease in adults
Sponsor/Manufacturer:
AbbVie Corporation
CDA-AMC Project Number:
SR0767-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: